BioSim welcomes the public consultation on the European Network of Medicines Agencies Strategy to 2025 and calls for further action to maximize the opportunities for increased access and lower cost provided by biosimilars.
BioSim News
BioSim welcomes the public consultation on the European Network of Medicines Agencies Strategy to 2025 and calls for further action to maximize the opportunities for increased access and lower cost provided by biosimilars.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.